Eagle Pharmaceuticals, Inc.

NEW YORK STATE COMMON RETIREMENT FUND EGRX

Report date

6/30/2024

Quarter

2024 Q2

Filed

10/8/2025

Shares

90

Value ($000)

1

Weight

0.0%

2019 Q4 - 2024 Q2 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q2	10/8/2025	1	0.0%	90	6/30/2024
2024 Q1	10/8/2025	33	0.0%	6,390	3/31/2024
2023 Q4	10/8/2025	33	0.0%	6,390	12/31/2023
2023 Q3	10/8/2025	101	0.0%	6,414	9/30/2023
2023 Q2	10/8/2025	298	0.0%	15,319	6/30/2023
2023 Q1	10/8/2025	483	0.0%	17,041	3/31/2023
2022 Q4	10/8/2025	776	0.0%	26,564	12/31/2022
2022 Q3	11/8/2022	222	0.0%	8,390	9/30/2022
2022 Q2	8/4/2022	372	0.0%	8,377	6/30/2022
2022 Q1	7/1/2022	416	0.0%	8,405	3/31/2022
2021 Q4	2/2/2022	428	0.0%	8,398	12/31/2021
2021 Q3	11/2/2021	470	0.0%	8,430	9/30/2021
2021 Q2	8/2/2021	453	0.0%	10,584	6/30/2021
2021 Q1	5/11/2021	438	0.0%	10,500	3/31/2021
2020 Q4	2/8/2021	540	0.0%	11,600	12/31/2020
2020 Q3	11/5/2020	493	0.0%	11,600	9/30/2020
2020 Q2	8/7/2020	557	0.0%	11,600	6/30/2020
2020 Q1	5/6/2020	437	0.0%	9,500	3/31/2020
2019 Q4	2/5/2020	571	0.0%	9,500	12/31/2019